Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - OTHER CURRENT LIABILITIES
Other Current Liabilities CHRS - Coherus BioSciences, Inc.
294 M
LAST VALUE
42.16%
2 YEAR CAGR
74.94%
5 YEAR CAGR
25.03%
10 YEAR CAGR